| Literature DB >> 31877633 |
Rikard Landberg1, Kati Hanhineva1,2.
Abstract
Whole diets and dietary patterns are increasingly highlighted in modern nutrition and health research instead of single food items or nutrients alone. The Healthy Nordic Diet is a dietary pattern typically associated with beneficial health outcomes in observational studies, but results from randomized controlled trials are mixed. Dietary assessment is one of the greatest challenges in observational studies and compliance is a major challenge in dietary interventions. During the last decade, research has shown the great importance of the gut microbiota in health and disease. Studies have have both shown that the Nordic diet affects the gut microbiota and that the gut microbiota predicts the effects of such a diet. Rapid technique developments in the area of high-throughput mass spectrometry have enabled the large-scale use of metabolomics both as an objective measurement of dietary intake as well as in providing the final readout of the endogenous metabolic processes and the impact of the gut microbiota. In this review, we give an update on the current status on biomarkers that reflect a Healthy Nordic Diet or individual components thereof (food intake biomarkers), biomarkers that show the effects of a Healthy Nordic Diet and biomarkers reflecting the role of a Healthy Nordic Diet on the gut microbiota as well as how the gut microbiota or derived molecules may be used to predict the effects of a Healthy Nordic Diet on different outcomes.Entities:
Keywords: Nordic diet; biomarkers; metabolomics; microbiota; personalized nutrition
Mesh:
Substances:
Year: 2019 PMID: 31877633 PMCID: PMC7019922 DOI: 10.3390/nu12010027
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Putative biomarkers reflecting the intake of a Healthy Nordic Diet derived from dietary intervention studies with Healthy Nordic Diets and observational studies where adherence to Healthy Nordic Diet-related food indices were measured.
| Type of Study | Participants | Duration/Follow-Up | Foods/Dietary Instrument | Sample/Analysis | Metabolites That Differed between Diets/Adherence to Indices | Type of Biomarkers | Ref. |
|---|---|---|---|---|---|---|---|
| Intervention study, parallel | In total, 181, overweighed + one MetS risk factor | 6 months | New Nordic diet 1 vs. habitual Danish diet/repeated weighed food records and foods provided in an intervention shop | 24-Urine/UPLC-QTOF-MS 1 | In total, 52 metabolites explained differences between the diets, but trimethylamine N-oxide, hippuric acid, hydroquinone-glucuronide, | Compliance biomarkers | [ |
| Intervention study, parallel | In total, 161, overweighted + one MetS risk factor | 6 months | New Nordic diet1 vs. habitual Danish diet/repeated weighed food records and foods provided in an intervention shop | Fasting plasma/GC–MS 1 | In total, 33 metabolites differentiated between groups but 3-hydroxybutanoic acid, erythritol, 2-hydroxybenzoic acid, aspartic acid, 2,3,4-trihydroxybutanoic | Effect biomarkers, biomarkers of weight loss, seasonality biomarkers and dietary biomarkers | [ |
| Intervention study, parallel | In total, 161, overweighted + one MetS risk factor | 6 months | New Nordic diet 2 vs. habitual Danish diet/repeated weighed food records and foods provided in an intervention shop | Fasting plasma/UPLC-QTOF-MS | Food intake-related metabolites included theobromine (chocolate), proline betaine (citrus), products of food heating (a cyclic dipeptide, i.e., cyclo(pro-val)), fish (TMAO),products of animal protein metabolism (a tryptophan metabolite, indolelactic acid), and novel markers of other food groups (i.e., pipecolic acid betaine and prolyl-hydroxyproline). Endogenous metabolites shifted included butyryl carnitine, 2-hydroxy-3-methylbutyrate, specific phospholipids and plasmalogens | Effect biomarkers, biomarkers of weight loss, seasonality biomarkers and dietary biomarkers | [ |
| Intervention, parallel | In total, 106 men and women with MetS | 12 weeks | (1) whole grains + fatty fish + billberries; (2) whole grains; (3) refined wheat/weighed food records | Fasting plasma/UPLC-QTOF-MS | Glucuronidated alk(en)- | Food intake biomarkers and effect biomarkers | [ |
| Intervention, parallel, multicenter | In total, 213 (166 completed) men and women with metabolic syndrome | 18–24 weeks depending on study center | Healthy Nordic Diet 3 including whole grain products, berries, fruit and vegetables, | Fasting plasma/LC-QQQ-MS 1 | Pipecolic acid betaine (PAB) was significantly higher in the Healthy Nordic Diet group than in the control group at the end of the intervention. No other metabolites differed significantly | Effect biomarkers | [ |
| Observational, nested case-control study | In total, 421 case-control pairs of healthy men and women | Adherence to the Healthy Nordic Food Index and Baltic Sea Diet Score; FFQ | Fasting plasma/ UPLC-QTOF-MS | In total, 31 metabolites were associated with BSDS and/or HNFI. Five metabolites were associated with both indices: docosahexaenoic acid (DHA), lysophatidylethanolamine (lysoPE 22:6), γ-tocopherol, and two unknown metabolites | Food intake biomarkers and effect biomarkers | [ |
1 Abbreviations: ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS); Gas Chromatrography-Mass Spectrometry (GC-MS); Liquid Chromatography-triple Quadrupole Mass Spectrometry (LC-QQQ-MS); Baltic Sea Diet Score (BSDS); Healthy Nordic Food Index (HNFI). 2 Food items from 15 food groups such as vegetables, fruits, berries, whole grains, nuts and seafood products were included (see [50]). 3 For a detailed description of the diets, see Uusituppa et al. [10].
Figure 1The reported and yet unknown applications of metabolite biomarkers reflecting effects, dietary intake/adherence of a Healthy Nordic diet in observational and intervention studies at the population-, group- and individual levels. Moreover, the effects of a Healthy Nordic Diet on the gut microbiota as well as the use of the gut microbiota to assess differential responses for intertypes (group level) or at individual level. LDL-low density lipoprotein; T2D-type 2 diabetes.